PSD3 acted as a potential biomarker predicting relapse of acute myeloid leukemia in cytogenetically normal adult patients and involved in breast cancer metastasis, astrocytoma and papillary thyroid cancer progression 35. Here, PSD3 is linked to breast cancer.